Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 14 subfamily A member 16 (OR14A16) is a **G protein-coupled receptor (GPCR)** expressed in humans, encoded by the OR14A16 gene[1][2][5][9][10]. OR14A16 participates in **olfaction** by interacting with odorant molecules in the nose, initiating a neuronal response that triggers the perception of smell[1][5][10]. Structurally, it belongs to the large olfactory receptor family and possesses the characteristic **7-transmembrane domain** found in many neurotransmitter and hormone receptors[1][5][9][10]. While the principal function is odorant signal recognition and transduction, OR14A16 and related olfactory receptors have also been detected in non-olfactory tissues, and there is some evidence associating OR14A16 with prostate cancer, though its broader physiological and pathophysiological roles remain under investigation[5][7]. There are no known drugs currently targeting OR14A16, and it is not established as a therapeutic target in clinical practice[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 14 subfamily A member 16 (OR14A16).